General
Preferred name
SALSALATE
Synonyms
Disalicylic acid ()
Salicylsalicylic acid ()
Sasapyrine ()
NSC-49171 ()
NSC-49171,Salsalate ()
Salicylic acid, bimolecular ester ()
Salsalato ()
Disalicyclic acid ()
Disalcid ()
P&D ID
PD002223
CAS
552-94-3
Tags
available
drug
prodrug
Approved by
FDA
Drug indication
Fever
Rheumatoid arthritis
Drug Status
approved
investigational
Max Phase
2.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
DESCRIPTION Salsalate is a potent antirheumatic drug with oral activity that reduces irritation during gastric absorption and avoids direct inhibition of cyclooxygenase. Salsalate not only has significant anti-inflammatory effects, but also reduces blood sugar levels, improves insulin resistance, and reduces the expression of cytokines. Salsalate can protect mice from metabolic disorders caused by high-fat diet and effectively improve the symptoms of type 2 diabetes, atherosclerosis and non-alcoholic steatohepatitis[1][2 ][3][4][5][6].
DESCRIPTION Salsalate (Sasapyrine) is an orally available salicylate and non-steroidal anti-inflammatory drug (NSAID), with anti-inflammatory, analgesic and antipyretic activities. (TargetMol Bioactive Compound Library)
Compound Sets
18
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Ki Database
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
74
Properties
(calculated by RDKit )
Molecular Weight
258.05
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
2
Aromatic Ring Count
2
cLogP
2.31
TPSA
83.83
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.65
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
NF-¦ÊB
Immunology/Inflammation
Metabolic Enzyme/Protease
NF-κB
Metabolism
Neuroscience
Target
COX-1
COX-2
Reactive Oxygen Species
PTGS1, PTGS2
Immunology & Inflammation related
Reactive Oxygen Species (ROS)
Member status
member
MOA
inhibition of p300-induced Tau acetylation
Non-Steroidal Antiinflammatory Drugs
NF-kappaB (NFKB) Activation Inhibitors
NFkB pathway inhibitor
Indication
osteoarthritis, rheumatoid arthritis
Therapeutic Class
Antiinflammatory Agents
Source data